We are monitoring the impact of COVID-19 on Europe Aptamers Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1073
Share on
Share on

Europe Aptamers Market Research Report - Segmented By Type, Application, End User, & By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis on Size, Share, Trends, Forecast, Growth | 2019 - 2024

Pulished: February, 2020
ID: 1073
Pages: 145

Europe Aptamers Market Size & Growth (2019 – 2024):

The Size of the Aptamers Market in Europe is valued at USD 43.51 Million in 2019 and estimated to reach USD 108.27 Million by the end of 2024, at a growing potential of 20.00 % during the forecast period 2019-2024.

Aptamers are oligonucleotides that bind to a target protein, lipid, or nucleic acid molecules with a high specificity. Due to the increasing number of opportunities I.e, drug discovery, biomarker discovery, and diagnostics segments in the market number of players entering the market. The potential of aptamers in diagnostics and therapeutics has been recognized by the launch of the first aptamer, Macugen. So, the European market for aptamers is expected to grow, which has been backed by advancements in technology with respect to selection processes and synthesis.

The Major factors driving the growth of the European market are an advancement in technology, Growing R&D investments in pharmaceutical and biotechnology industries, low cost and high efficacy of aptamers in binding. Stringent regulations in the use of aptamers, slow in reaching the market place due to regulatory hurdles may hinder the growth of the market.     

This research report segmented and sub-segmented the Europe Aptamers Market into the following categories:

  • By Type: Peptide aptamers, Nucleic Acid aptamers. Nucleic Acid aptamers are further categorized into DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers.
  • By  Application: Therapeutics Development, Diagnostics, Research and Development
  • By End User: Pharmaceutical Companies, Bio-Pharmaceutical companies, Academic and Research Centres.
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe.

Some of the major companies dominating the Europe Aptamers market are AM Biotechnologies, Aptagen, Aptamer Sciences Inc., Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., SomaLogic Inc, TriLink BioTechnologies Inc., and Vivonics, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Peptide Aptamers

                                5.1.2 Nucleic Acid Aptamers       

                                                5.1.2.1 DNA-Based Aptamers

                                                5.1.2.2 RNA-Based Aptamers

                                                5.1.2.3 XNA-Based Aptamers

                5.2 By Application                           

                                5.2.1 Therapeutics Development             

                                5.2.2 Diagnostics             

                                5.2.3 Research and Developments          

                5.3 By End Users                             

                                5.3.1 Pharmaceutical Companies             

                                5.3.2 Bio-Pharmaceutical Companies     

                                5.3.3 Academic and Research Centers    

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 U.K

                                6.3 Spain             

                                6.4 Germany     

                                6.5 Italy               

                                6.6 France          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 AM Biotechnologies               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Aptagen                      

                8.3 Aptamer Sciences Inc.                            

                8.4 Aptamer Solutions Ltd                           

                8.5 Aptus Biotech S.L.                    

                8.6 Base Pair Biotechnologies Inc                             

                8.7 NeoVentures Biotechnology Inc.                       

                8.8 SomaLogic Inc                           

                8.9 TriLink BioTechnologies Inc                  

                8.10 Vivonics, Inc                            

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Aptamers Market By Type, From 2019-2024( USD Million )
  2. Europe Peptide Aptamers Market By Region, From 2019-2024( USD Million )
  3. Europe Nucleic Acid Aptamers Market By Region, From 2019-2024( USD Million )
  4. Europe Aptamers Market By Application, From 2019-2024( USD Million )
  5. Europe Therapeutics Development Market By Region, From 2019-2024( USD Million )
  6. Europe Diagnostics Market By Region, From 2019-2024( USD Million )
  7. Europe Research and Development Market By Region, From 2019-2024( USD Million )
  8. Europe Aptamers Market By End users, From 2019-2024( USD Million )
  9. Europe Pharmaceutical Companies Market By Region, From 2019-2024( USD Million )
  10. Europe Bio-Pharmaceutical Companies Market By Region, From 2019-2024( USD Million )
  11. Europe Academic and Rsearch centers Market By Region, From 2019-2024( USD Million )
  12. U.K. Aptamers Market By Type, From 2019-2024( USD Million )
  13. U.K. Aptamers Market By Application, From 2019-2024( USD Million )
  14. U.K. Aptamers Market By End users, From 2019-2024( USD Million )
  15. Germany Aptamers Market By Type, From 2019-2024( USD Million )
  16. Germany Aptamers Market By Application, From 2019-2024( USD Million )
  17. Germany Aptamers Market By End users, From 2019-2024( USD Million )
  18. France Aptamers Market By Type, From 2019-2024( USD Million )
  19. France Aptamers Market By Application, From 2019-2024( USD Million )
  20. France Aptamers Market By End users, From 2019-2024( USD Million )
  21. Italy Aptamers Market By Type, From 2019-2024( USD Million )
  22. Italy Aptamers Market By Application, From 2019-2024( USD Million )
  23. Italy Aptamers Market By End users, From 2019-2024( USD Million )
  24. Spain Aptamers Market By Type, From 2019-2024( USD Million )
  25. Spain Aptamers Market By Application, From 2019-2024( USD Million )
  26. Spain Aptamers Market By End users, From 2019-2024( USD Million )
  27. Europe Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Million )
  28. Europe DNA Based Aptamers Market By Region, From 2019-2024( USD Million )
  29. Europe RNA Based Aptamers Market By Region, From 2019-2024( USD Million )
  30. Europe XNA Based Aptamers Market By Region, From 2019-2024( USD Million )
  31. U.K. Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Million )
  32. Germany Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Million )
  33. France Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Million )
  34. Italy Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Million )
  35. Spain Aptamers Market By Nucleic Acid Aptamers, From 2019-2024( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample